Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Lymphoma 3Uterine Cervical Neoplasms 2Papillomavirus Infections 2Pancreatic Neoplasms 2Head and Neck Neoplasms 2Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Thyroid Nodule 1Small Cell Lung Carcinoma 1Precancerous Conditions 1Pancreatitis, Chronic 1Pancreatic Cyst 1Mouth Diseases 1Lung Neoplasms 1Kidney Neoplasms 1Hematuria 1Gastrointestinal Stromal Tumors 1Endometrial Neoplasms 1Cholangiocarcinoma 1Cervical Intraepithelial Neoplasia Grade 2/3 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Biopsy, Fine-Needle 1Anus Neoplasms 1

Interventions

Papanicolaou Test 1Cytological Techniques 1Colposcopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cervical Intraepithelial Neoplasia Grade 2/3 × Cytological Techniques × Clear all
NCT03366493 2017-12-08

The Study of Folate Receptor-Mediated Staining Solution (FRDâ„¢) In Cervical Lesion Detection

GY Highland Biotech LLC

Phase 3 Unknown
200 enrolled
Gynecologic

Cervical Intraepithelial Neoplasia Grade 2/3

Data powered by HemOnc (CC BY 4.0) Colophon âš¡